A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats

• Pierre E. Signore,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  ⨯
• Guangjie Guo,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  ⨯
• Zhihua Wei,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  ⨯
• Weihua Zhang,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  ⨯
• Al Lin,

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  ⨯
• Ughetta del Balzo

  Roles Conceptualization, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: udelbalzo@fibrogen.com

  Affiliation FibroGen, Inc., San Francisco, CA, United States of America

  https://orcid.org/0000-0003-4102-6023

  ⨯